Strides Arcolab has merged its Australian and Asian businesses with Genepharm Australasia to the distribute of Genepharm’s Pharma and OTC products

Strides Arcolab has merged its Australian and Asian businesses with Genepharm Australasia. As part of the agreement, Strides will have access to the distribution of Genepharm’s Pharma and OTC products. Both companies will enter into a five-year Strides preferred supply agreement, under which Genepharm will have the first right of refusal to distribute all existing and future Strides’ products into Australia, New Zealand and Asian regions, excluding Japan and China, where Genepharm will have the non-exclusive right to supply Strides’ products.

Arun Kumar, vice-chairman and managing director, Strides, said that a strong regional market play and see better value in smaller markets.